Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Holding KIDS?
Track your performance easily
KIDS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.02 - $36.23
Previous Close$27.36
Volume196.89K
Average Volume (3M)160.81K
Market Cap
$662.51M
Enterprise Value$633.74M
Total Cash (Recent Filing)$28.93M
Total Debt (Recent Filing)$156.00K
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Nov 06, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding24,214,426
10 Day Avg. Volume93,933
30 Day Avg. Volume160,807
Standard Deviation0.12
R-Squared0.26
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.78
Price to Sales (P/S)3.78
Price to Cash Flow (P/CF)-27.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.62
Enterprise Value/Gross Profit5.70
Enterprise Value/Ebitda-53.74
Forecast
1Y Price Target
$41.33Price Target Upside43.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
OrthoPediatrics News
PremiumCompany Announcements
OrthoPediatrics Showcases Growth and Outlook in Investor Presentations
PremiumCompany Announcements
OrthoPediatrics Enhances Investor Relations with Strategic PresentationsBulls Say, Bears Say
Bulls Say
Growth StrategyThe company announced a new private financing of $100 mln with Braidwell LP, which should enable the company to reach cashflow breakeven.
Market Position And PotentialKIDS is viewed as a differentiated participant in the largely underserved pediatric-orthopedic industry, with the potential to achieve further penetration in its base markets and enter complementary, attractive orthopedic arenas.
ValuationKIDS shares trade at 2.1x NTM EV/Sales, which is below peers at 7.6x NTM EV/Sales, making it an attractive valuation.
Bears Say
Health Crisis ImpactThe business has been negatively impacted by COVID-19 and its lingering headwinds.
Ongoing ChallengesBoth COVID-19 and RSV have created negative challenges for the business.
Pandemic EffectsRSV has contributed to a negative impact on the business.
---
Ownership Overview
32.46% Insiders
18.38% Mutual Funds
3.27% Other Institutional Investors
37.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $24.02 and its highest was $36.23 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
Currently, no data Available
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Nov 06, 2024 which is tomorrow.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Aug 05, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.263 by $0.033.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -$0.23.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 24,214,426 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.263. Following the earnings report the stock price went down -6.129%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Among the largest hedge funds holding OrthoPediatrics Corp’s share is Royce & Associates LLC. It holds OrthoPediatrics Corp’s shares valued at 380K.
---
OrthoPediatrics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$41.33 (43.81% Upside)
$41.33 (43.81% Upside)
Hedge Fund Trend
Decreased
By 50.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $293.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.08%
12-Months-Change
Fundamentals
Return on Equity
-6.68%
Trailing 12-Months
Asset Growth
-0.94%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
---
KIDS Earnings Call
Q2 2024
0:00 / 0:00
---
KIDS Stock 12 Month Forecast
Average Price Target
$41.33
▲(43.81% Upside)
Technical Analysis
Paragon 28
―
Inspire Medical Systems
―
Tandem Diabetes Care
―
Axonics Modulation Technologies
―
Best Analysts Covering KIDS
1 Year
1 Year Success Rate
7/27 ratings generated profit
1 Year Average Return
-10.12%
reiterated a buy rating 2 months ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 25.93% of your transactions generating a profit, with an average return of -10.12% per trade.
---